Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

NCT01422486 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Study TLK199.2107 was terminated for business reasons.

Conditions

Myelodysplastic Syndrome (MDS)

Interventions

DRUG: ezatiostat hydrochloride (Telintra®)

Sponsor

Telik